Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “standard”

15 pharma patents match "standard" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 15
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 15 pharmaceutical patents matching "standard" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

15 results for “standard” · 30,257 patents in full index Clear search

  1. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12090227

    Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion

    STANDARD FOODS (CHINA) CO., LTD · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  3. US 11963970

    Preparation method of ginseng composition with high ginsenoside bioavailability

    STANDARD FOODS (CHINA) CO., LTD · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  4. US 11077241

    Standardizations and medical devices for the preparation of platelet rich plasma (PRP) or bone marrow concentrate (BMC) alone or in combination with hyaluronic acid

    RegenLab USA LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  5. US 10076527

    Standardized extract and its use in the manufacture of a medicament

    Botanic Century (Beijing) Co. Ltd. · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  6. US 9198645

    Controlled vesicle self-assembly in continuous two phase flow microfluidic channels

    The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  7. US 9056046

    Standardized extract and its use in the manufacture of a medicament

    Botanic Century (Beijing) Co. Ltd. · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted
  8. US 8715591

    Microfluidic apparatus to control liposome formation

    The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology · Granted May 6, 2014 · Expires May 1, 2034

    granted
  9. US 8487097

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted
  10. US 7741482

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  11. US 7692008

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  12. US 7692009

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  13. US 7692010

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  14. US 7378553

    Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted May 27, 2008 · Expires May 22, 2028

    granted
  15. US 7244844

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 17, 2007 · Expires Jul 12, 2027

    granted